Preview

Vestnik Moskovskogo universiteta. Seriya 16. Biologiya

Advanced search

Molecular dynamics simulation of the conformational mobility of the lipid-binding site in the Apolipoprotein E isoforms ε2, ε3, and ε4

https://doi.org/10.55959/MSU0137-0952-16-78-2-3

Abstract

Neurodegenerative disorders, particularly Alzheimer’s disease, have become a major healthcare issue all over the world. Despite extensive research, the molecular mechanisms underlying these conditions are yet to be identified. APOE is the apolipoprotein E-coding gene. Its polymorphisms have been found to be significantly associated with both neurodegenerative disorders (rs429358, C112R) and protective effects against these disorders (rs7412, R158C). Humans carry three apolipoprotein E isoforms: ε2 (protein with a protective mutation), ε3 (wild-type protein), and ε4 (protein with a pathogenic mutation). The study sought to investigate how these substitutions affect the lipid-binding site, which is the functional region of the protein. Molecular dynamics simulation was used to analyze all three isoforms. We found that, unlike the wild-type isoform, both the pathogenic and protective mutations caused changes in the lipid-binding site. The changes, however, were different. Both ε2 and ε4 lead to an increased distance between the N-terminal (amino acids 88-104) and the C-terminal (amino acids 251-266) helices. However, in ε2, the C-terminal helix retained its structure, whereas in ε4, it unwound between amino acids 260 and 266. The opposite was true for the N-terminal helix. It is safe to assume that it is these structural differences in the lipid-binding site that account for the different effects of these two isoforms and clinical characteristics of their carriers. The clustering analysis allowed for the identification of the structures, most typical of ε2 and ε4, which could be used as the foundation for further molecular dynamics studies.

About the Authors

A. A. Mamchur
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia); Lomonosov Moscow State University
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121;

Department of Biophysics, School of Biology, 

1–12 Leninskie gory, Moscow, 119234



V. V. Erema
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



D. A. Kashtanova
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



M. V. Ivanov
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



V. S. Yudin
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



A. A. Keskinov
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



S. A. Kraevoy
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



S. M. Yudin
Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia)
Russian Federation

10-1 Pogodinskaya str., Moscow, 119121



References

1. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer’s disease. Lancet. 2011;377(9770):1019–1031.

2. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(2):327–406.

3. Huang Y, Mahley R.W. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases. Neurobiol. Dis. 2014;72(Pt. A):3–12.

4. Deelen J., Evans D.S., Arking D.E., Tesi N., Nygaard M., Liu X., et al. A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat. Commun. 2019;10:3669.

5. Chen J., Li Q., Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc. Natl. Acad. Sci. U.S.A. 2011;108(36):14813–14818.

6. Frieden C., Wang H., Ho C.M.W. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain–domain interactions. Proc. Natl. Acad. Sci. U.S.A. 2017;114(24):6292–6297.

7. Tsiolaki P.L. Katsafana A.D., Baltoumas F.A., Louros N.N., Iconomidou V.A. Hidden aggregation hotspots on human apolipoprotein E: A structural study. Int. J. Mol. Sci. 2019;20(9):2274.

8. Zhang Y., Vasudevan S., Sojitrawala R., Zhao W., Cui C., Xu C., Fan D., Newhouse Y., Balestra R., Jerome W.G., Weisgraber K., Li Q., Wang J. A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry. 2007;46(37):10722–10732.

9. Hatters D.M., Peters-Libeu C.A., Weisgraber K.H. Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 2006;31(8):445–454.

10. Abraham M.J., Murtola T., Schulz R., Pall S., Smith J.C., Hess B., Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25.

11. Klauda J.B., Venable R.M., Freites J.A., O’Connor J.W., Tobias D.J., Mondragon-Ramirez C., Vorobyov I., MacKerell A.D., Pastor R.W. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B. 2010;114(23):7830–7843.

12. Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007;126(1):014101.

13. Parrinello M., Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981;52(12):7182–7190.

14. Jorgensen W.L., Chandrasekhar J., Madura J.D., Impey R.W., Klein M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983;79(2):926–935.

15. Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103(19):8577–8593.

16. Michaud-Agrawal N., Denning E.J., Woolf T.B., Beckstein O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 2011;32(10):2319–2327.

17. Tiberti M., Papaleo E., Bengtsen T., Boomsma W., Lindorff-Larsen K. ENCORE: Software for quantitative ensemble comparison. PLoS Comput. Biol. 2015;11(10):e1004415.


Supplementary files

1. Приложение
Subject
Type Other
Download (853KB)    
Indexing metadata ▾

Review

For citations:


Mamchur A.A., Erema V.V., Kashtanova D.A., Ivanov M.V., Yudin V.S., Keskinov A.A., Kraevoy S.A., Yudin S.M. Molecular dynamics simulation of the conformational mobility of the lipid-binding site in the Apolipoprotein E isoforms ε2, ε3, and ε4. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2023;78(2):70-77. (In Russ.) https://doi.org/10.55959/MSU0137-0952-16-78-2-3

Views: 493


ISSN 0137-0952 (Print)